SMA drug Zolgensma finally makes Alberta's Rare Diseases Drug Coverage Program
Coverage for Zolgensma, a gene therapy used to treat spinal muscular atrophy, is now permanently available in Alberta.
The therapy was added to the province's Rare Diseases Drug Coverage Program after the pan-Canadian Pharmaceutical Alliance (pCPA) reached a long-term pricing agreement with manufacturer Novartis Pharmaceuticals Canada Inc. in October.
Alberta Health Minister Jason Copping said in a statement the government was "extremely pleased" at the development and Alberta's new ability to offer the treatment on a more secure basis.
The province had been providing access to the drug on its own pending a national drug review, approval and the price negotiations with Novartis.
Zolgensma, a one-time treatment with a price tag of $2.91 million, is administered by intravenous infusion to replace a missing or faulty gene that results in spinal muscular atrophy (SMA). The rare disorder can cause a loss of muscle function and is seen in about one in 10,000 Canadian babies each year, according to the National Organization for Rare Disorders.
Zolgensma is supposed to stop the disease's progression and restore protein production of the missing or defective SMN1 gene. It must be administered when a patient is a toddler.
Several Alberta families led the push to have it approved and covered in Alberta and Canada.
Spinraza, a spinal injection given three times a year that can be used as a treatment for SMA, is also covered under the Alberta Drug Benefit List.
CTVNews.ca Top Stories
BREAKING Iran fires air defence batteries in provinces as sound of explosions heard near Isfahan
Iran fired air defence batteries early Friday morning after reports of explosions near the city of Isfahan, the state-run IRNA news agency reported.
American millionaire Jonathan Lehrer denied bail after being charged with killing Canadian couple
American millionaire Jonathan Lehrer, one of two men charged in the killings of a Canadian couple in Dominica, has been denied bail.
Nearly half of China's major cities are sinking, researchers say
Nearly half of China's major cities are suffering 'moderate to severe' levels of subsidence, putting millions at risk of flooding especially as sea levels rise.
Prince Harry formally confirms he is now a U.S. resident
Prince Harry, the son of King Charles III and fifth in line to the British throne, has formally confirmed he is now a U.S. resident.
Judge says 'no evidence fully supports' murder case against Umar Zameer as jury starts deliberations
The judge presiding over the trial of a man accused of fatally running over a Toronto police officer is telling jurors the possible verdicts they may reach based on the evidence in the case.
Health Canada to change sperm donor screening rules for men who have sex with men
Health Canada will change its longstanding policy restricting gay and bisexual men from donating to sperm banks in Canada, CTV News has learned. The federal health agency has adopted a revised directive removing the ban on gay, bisexual and other men who have sex with men, effective May 8.
Colin Jost names one celebrity who is great at hosting 'Saturday Night Live'
Colin Jost, who co-anchors Saturday Night Live's 'Weekend Update,' revealed who he thinks is one of the best hosts on the show.
Sports columnist apologizes for 'oafish' comments directed at Caitlin Clark. The controversy isn't over
A male columnist has apologized for a cringeworthy moment during former University of Iowa superstar and college basketball's highest scorer Caitlin Clark's first news conference as an Indiana Fever player.
'Shopaholic' author Sophie Kinsella reveals brain cancer diagnosis
Sophie Kinsella, the best-selling author behind the 'Shopaholic' book series, has revealed that she is receiving treatment for brain cancer.